This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Eosinophilic Gastroenteritis (EGE) Is An Inflammatory Condition That Affects The Digestive Tract. It Is A Rare Disorder And Often Difficult To Diagnose. EGE Is Characterized By An Accumulation Of White Blood Cells Called Eosinophils In The Lining Of The Stomach, Small Intestine, And/Or Large Intestine. This Inflammation Is Thought To Be Caused By An Allergic Reaction To Certain Foods, Medications, Or Environmental Factors. Symptoms Of EGE Include Abdominal Pain, Nausea, Vomiting, Diarrhoea, Bloating, And Weight Loss. Other Signs And Symptoms Of EGE May Include Anemia, Fatigue, And Skin Rashes. Diagnosis Of EGE Is Usually Made By A Combination Of Blood Tests, Endoscopy, And Biopsy. Treatment Of EGE Typically Involves Avoiding The Allergen That Is Causing The Inflammation And The Use Of Steroids To Reduce Inflammation. People With EGE Usually Require Lifelong Management Of The Condition. This Includes Dietary Changes, Such As Avoiding The Allergen That Is Causing The Inflammation, And Medications, Such As Oral Steroids. In Some Cases, Surgery May Be Necessary To Remove Affected Areas Of The Digestive Tract. In Conclusion, EGE Is A Rare And Difficult To Diagnose Inflammatory Condition Of The Digestive Tract. It Is Characterized By An Accumulation Of White Blood Cells Called Eosinophils. Treatment Of EGE Typically Involves Avoiding The Allergen That Is Causing The Inflammation, Dietary Changes, And Medications. People With EGE Usually Require Lifelong Management Of The Condition.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States